KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Intangibles (2019 - 2025)

GoodRx Holdings' Intangibles history spans 7 years, with the latest figure at $139.3 million for Q4 2025.

  • For Q4 2025, Intangibles rose 11.6% year-over-year to $139.3 million; the TTM value through Dec 2025 reached $139.3 million, up 11.6%, while the annual FY2025 figure was $139.3 million, 11.6% up from the prior year.
  • Intangibles for Q4 2025 was $139.3 million at GoodRx Holdings, up from $62.8 million in the prior quarter.
  • Across five years, Intangibles topped out at $139.3 million in Q4 2025 and bottomed at $32.0 million in Q2 2021.
  • The 5-year median for Intangibles is $89.1 million (2021), against an average of $88.2 million.
  • The largest annual shift saw Intangibles skyrocketed 348.44% in 2021 before it plummeted 49.13% in 2024.
  • A 5-year view of Intangibles shows it stood at $88.8 million in 2021, then skyrocketed by 35.0% to $119.9 million in 2022, then decreased by 20.38% to $95.4 million in 2023, then surged by 30.74% to $124.8 million in 2024, then rose by 11.6% to $139.3 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Intangibles are $139.3 million (Q4 2025), $62.8 million (Q3 2025), and $138.3 million (Q2 2025).